Remove 2012 Remove Invention Remove Litigation Remove Patent Infringement
article thumbnail

Hot-Tubbing in Indian IP Litigation: Delhi High Court Issues Directives in High-Stakes Patent Infringement Case

SpicyIP

This high-profile case revolves around allegations of patent infringement concerning two patents (“Suit Patents”), both relating to ‘Pertuzumab,’ a monoclonal antibody (Mab) biologic used in inhibiting tumor growth. Find it here.

article thumbnail

Delhi High Court Directs Maharaja to Pay a King’s Ransom in a Patent Infringement Suit  

SpicyIP

Putting an end to a 24 year old patent infringement suit, the Delhi High Court has directed Maharaja Appliances Ltd. Background The dispute started off as a heated battle between the parties over the plaintiff’s ‘Liquid Heating Vessels’ patent, which the plaintiff claimed was used by the defendant in its electric kettles.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Keeping up with Belgian patent litigation: Year case law review 2021

The IPKat

The winds of a busy Belgian court term blows through the IPKat's wild ancestor's mane (c) Christopher Stothers 'Tis the season for a look at the cases that were in 2021 from around Europe and what they mean for the IP litigation themes in those jurisdictions now that the dust has settled in 2022. The decisions we (arbitrarily!)

article thumbnail

DoggyPhone v Furbo

Patently-O

In his spare time he invents canine communication devices and treat dispensers. Figure 9 below comes from his US9723813 (2012 priority date). DoggyPhone has sued Tomofun (maker of Furbo) for patent infringement. The district court had stayed litigation pending outcome of the IPR. DoggyPhone LLC v. Tomofun, LLC. ,

article thumbnail

Is Messenger RNA Patent-Eligible?

SpicyIP

Patent eligible subject matter refers to subject matter that is inherently suited for patent protection. Section 3 of the Patents Act, 1970 is the key section on “patent eligibility” and lists out what are not “inventions”. 1289, 1293 (2012) ). For mRNA, sections 3(c), 3(d), 3(i) and 3(j) are of relevance.

Patent 78
article thumbnail

Guest Post by Prof. Contreras: A Statutory Anti-Anti-Suit Injunction for U.S. Patent Cases?

Patently-O

patent infringement proceedings, effectively creating a statutory “anti-anti-suit injunction” (AASI) applicable in all courts across the U.S. Essentially, an ASI is issued by a first court to prevent a party from pursuing litigation in a second court when it would interfere with the proceedings in the first court.

Patent 60
article thumbnail

Guest Post by Prof. Contreras: How the ‘Patent Eligibility Restoration Act’ Would Harm American Businesses and Endanger Global Health by Reintroducing ‘Pathogen Patents’

Patently-O

There Are Ample Patentable Innovations Relating to Disease Response and Containment Beyond Pathogen Sequences. It is also unnecessary to patent underlying pathogenic sequences in order to protect novel and innovative technologies such as diagnostics, vaccines and therapeutics. where fee shifting is rare.